21,608 Shares in Avidity Biosciences, Inc. (NASDAQ:RNA) Bought by BNP Paribas Financial Markets
BNP Paribas Financial Markets bought a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm bought 21,608 shares of the biotechnology company’s stock, valued at approximately $628,000. A number of other large investors also recently modified their holdings of RNA. Boxer Capital Management LLC purchased […]
BNP Paribas Financial Markets bought a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm bought 21,608 shares of the biotechnology company’s stock, valued at approximately $628,000. A number of other large investors also recently modified their holdings of RNA. Boxer Capital Management LLC purchased […]
